T24 Human Bladder Carcinoma Cells With Activated Ha-Ras Protooncogene: Nontumorigenic Cells Susceptible to Malignant Transformation With Carcinogen.

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.85.14.5107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Curcumin Enhances Chemosensitivity and Apoptosis in T24 Bladder Cancer Cells Through Inhibition of the Ras/ MAPK Signaling Pathway

Advances in Medicine and Medical Research
2018English

Bufalin Sensitizes Human Bladder Carcinoma Cells to TRAIL-mediated Apoptosis

Oncology Letters
Cancer ResearchOncology
2017English

Persistent Exposure to Mycoplasma Induces Malignant Transformation of Human Prostate Cells

PLoS ONE
Multidisciplinary
2009English

Suppression of C-Fos Gene Transcription With Malignant Transformation of Human Bronchial Epithelial Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

Human Papillomaviruses: Targeting Differentiating Epithelial Cells for Malignant Transformation

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Isolation of Enterococcus Faecalis Clinical Isolates That Efficiently Adhere to Human Bladder Carcinoma T24 Cells and Inhibition of Adhesion by Fibronectin and Trypsin Treatment

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
1999English

Apigenin Promotes Apoptosis, Inhibits Invasion and Induces Cell Cycle Arrest of T24 Human Bladder Cancer Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2013English

A Case of Urinary Bladder Tumor With Malignant Cells of Chorioncarcinoma and Transitional Cell Carcinoma in Urine

The Journal of the Japanese Society of Clinical Cytology
1980English

Expression of Normal and Activated Human Ha-Ras cDNAs in Saccharomyces Cerevisiae.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy